Related Experiment Video
Updated: Jul 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis
Nobuyuki Oyake1, Toshio Shimada, Yo Murakami
1Division of Cardiovascular Medicine, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Shimane, Japan.
Insights
Hepatitis C virus (HCV) infection is linked to increased aortic stiffness and cardiovascular events in patients undergoing hemodialysis. This study highlights HCV viremia as a key determinant of these cardiovascular complications in dialysis patients.
Area of Science:
- Nephrology
- Cardiology
- Hepatology
Background:
- The relationship between microorganisms and cardiovascular diseases is established, but the specific role of hepatitis C virus (HCV) in arteriosclerosis and cardiovascular events remains unclear.
- Chronic hemodialysis patients are at increased risk for cardiovascular complications.
Purpose of the Study:
- To investigate the association between HCV infection and increased aortic stiffness.
- To determine if HCV infection is linked to a higher incidence of cardiovascular events in chronic hemodialysis patients.
Main Methods:
- A prospective cohort study of 94 dialysis outpatients was conducted.
- Measurements included carotid-femoral pulse wave velocity (PWV), echocardiographic parameters, and serum HCV-RNA levels.
- Statistical analyses included logistic regression and Cox proportional hazard models to identify independent determinants of high PWV and cardiovascular events.
Main Results:
- HCV-positive patients exhibited higher aortic PWV and lower serum cholesterol levels.
- HCV viremia, mean blood pressure, and hemoglobin A1c were independent determinants of high PWV.
- HCV viremia, aortic PWV, pulse pressure, and left ventricular mass index were associated with cardiovascular events during follow-up.
Conclusions:
- HCV infection is significantly associated with increased aortic stiffness in dialysis patients.
- HCV infection is closely linked to a higher risk of cardiovascular events in this patient population.
Background:
Although links have been found between microorganisms and cardiovascular diseases, the role of hepatitis C virus (HCV) infection in the pathogenesis of arteriosclerosis and cardiovascular events is unclear. The primary objective of this research was to examine whether HCV infection is associated with increased aortic stiffness and cardiovascular events in chronic hemodialysis patients.
Subjects And Methods:
A prospective cohort study was conducted in 94 dialysis outpatients from October 2002 to October 2004. Measurements included carotid-femoral pulse wave velocity (PWV), echocardiographic parameters, serum HCV-RNA (positive in 17 patients), and several items of biochemical data. Multiple logistic regression and the Cox proportional hazard model were used to assess independent determinants of high aortic PWV (> or =10.0 m/sec, mean) and cardiovascular events (including cerebral and peripheral vascular events), adjusting for several risk factors and duration of dialysis.
Results:
The HCV-positive group had higher aortic PWV and lower serum cholesterol levels. Multivariate analysis indicated mean blood pressure, hemoglobin A1c and HCV viremia to be independent determinants of high PWV. During the follow-up period, 13 patients suffered from cardiovascular events. Prevalence of the diseases at baseline, pulse pressure, left ventricular mass index, HCV viremia and aortic PWV were associated with cardiovascular events. The Kaplan-Meier analysis indicated a significant difference in event-free rates between HCV-positive and HCV-negative patients.
Conclusion:
HCV infection is closely associated with increased aortic stiffness and cardiovascular event in dialysis patients.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Cirrhosis II: Pathophysiology
Hemodialysis II: Procedure and Complications
Hepatitis
Hypertension II: Pathophysiology

